Which of the following DPP IV inhibitors does not require dose modification in Chronic kidney disease patients: (A) Sitagliptin, (B) Vildagliptin, (C) Linagliptin, (D) All of the above
Answer is C. Linagliptin is is DPP IV inhibitors does not require dose modifications in Chronic kidney disease patients and can be used even in stage 5 ckd patients .